Delivery Order SPE2DB20D3103-SPE2DB24FN2K0
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Sandostatin LAR Depot 30 mg kits. The $17,709.77 firm fixed-price delivery order, which is not set aside, has an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, that serves as a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,061.38, is a delivery order for Sandostatin LAR Depot 20 mg kits. The contract has a final completion date of March 28, 2025 and utilizes a firm fixed price pricing structure. The contract is not designated with a set-aside, indicating open competition. AmerisourceBergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,336.65 firm fixed-price delivery order contract is for the provision of Sandostatin LAR Depot 20 mg kits, a specialty medication. The contract has an ultimate completion date of November 3, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for a Delivery Order from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Sandostatin LAR Depot 30 mg kits. The award, with a ceiling value of $21,118.00, is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a potential value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,496.96 firm fixed-price contract is for the delivery of Sandostatin LAR Depot 30 mg Kits, a specialty medication. The contract has an ultimate completion date of April 2, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...
- This federal contract award, with the ID SPE2DB20D3101|SPE2DB23FRCQ7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,204.98, is for the delivery of Sandostatin LAR Depot 30 mg kits. It is a firm fixed-price delivery order contract with a completion date of February 15, 2023. The contract does not have a set-aside designation, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Sandostatin LAR Depot 30 mg kits. The contract has a ceiling value of $15,784.56 and an ultimate completion date of December 29, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which...
- The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract worth $33,187.08 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a period of performance through March 18, 2025, is for the supply of Sandostatin LAR Depot 30 mg kits, a specialty medication used in the treatment of various medical conditions. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award is for the delivery of Sandostatin LAR Depot 30 mg kits to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $8,813.00 and a completion date of December 13, 2024. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves...
- This federal contract award is for the delivery of Sandostatin LAR Depot 30 mg kits to the Defense Logistics Agency (DLA). The $30,995.42 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 12, 2024, with a completion date of December 13, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN2K0Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,496.96, is for the delivery of Sandostatin LAR Depot 30 mg medical kits. The contract has a completion date of April 2, 2024 and is a firm fixed-price delivery order. The award is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 4/1/24 |